As the downstream signal of ERα, ARSD is able to restrain YAP/TAZ activation and cancer cell proliferation through acting on the Hippo signaling pathway, implying that ARSD can be a potential target in breast cancer.62 Here, ARSD is linked to breast carcinoma.